Richard Gates - Apr 20, 2023 Form 3 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Role: SVP, Chief Pharmacy Officer
Signature: /s/ Richard Gates by Cherita Thomas, Attorney-in-Fact
Stock symbol: WBA
Transactions as of: Apr 20, 2023
Transactions value $: $0
Form type: 3
Date filed: 5/1/2023, 09:52 PM
Next filing: Oct 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	WBA	Common Stock						26.2K	Apr 20, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	3.23K	$60.52	Direct
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	2.55K	$64.22	Direct
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	2.74K	$84.68	Direct
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	3.81K	$82.46	Direct
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	7.07K	$67.01	Direct	F3
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	9.07K	$79.90	Direct	F4
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	9.19K	$57.38	Direct	F5
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	10.8K	$34.04	Direct	F6
holding	WBA	Employee Stock Option (Right to Buy)							Apr 20, 2023	Common Stock	11K	$47.32	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes shares underlying restricted stock units ("RSUs") granted under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "2013 Plan"), RSUs granted under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "2021 Plan") and shares underlying RSUs issued in lieu of dividends (through April 30, 2023) on the outstanding RSUs. (continued in footnote 2)
F2	(continued from footnote 1) RSUs were granted and vest as follows (a) 722 RSUs granted on November 1, 2020 and vest on November 1, 2023; (b) 1,217.5 RSUs granted on November 1, 2021 that vest with respect to 607.5 units on November 1, 2023 and with respect to 610 units on November 1, 2024; and (c) 9,058 RSUs granted on November 1, 2022 that vest with respect to 3,016 units on November 1, 2023, with respect to 3,016 units on November 1, 2024, and with respect 3,026 units on November 1, 2025.
F3	The option vests with respect to 2,352 shares on November 1, 2018, with respect to 2,353 shares on November 1, 2019, and with respect to 2,360 shares on November 1, 2020, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan.
F4	The option vests with respect to 3,021 shares on November 1, 2019, with respect to 3,021 shares on November 1, 2020, and with respect to 3,031 shares on November 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan.
F5	The option vests with respect to 3,060 shares on November 1, 2020, with respect to 3,061 shares on November 1, 2021, and with respect to 3,070 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan.
F6	The option vests with respect to 3,606 shares on November 1, 2021, with respect to 3,606 shares on November 1, 2022, and with respect to 3,617 shares on November 1, 2023, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2013 Plan.
F7	The option vests with respect to 3,646 shares on November 1, 2022, with respect to 3,647 shares on November 1, 2023, and with respect to 3,658 shares on November 1, 2024, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the 2021 Plan.